John A. Colwell

13.2k total citations · 1 hit paper
154 papers, 7.1k citations indexed

About

John A. Colwell is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, John A. Colwell has authored 154 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Endocrinology, Diabetes and Metabolism, 55 papers in Cardiology and Cardiovascular Medicine and 41 papers in Surgery. Recurrent topics in John A. Colwell's work include Antiplatelet Therapy and Cardiovascular Diseases (43 papers), Diabetes Treatment and Management (33 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers). John A. Colwell is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (43 papers), Diabetes Treatment and Management (33 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (26 papers). John A. Colwell collaborates with scholars based in United States, Australia and Philippines. John A. Colwell's co-authors include Maria F. Lopes‐Virella, Stephen G. Ellis, Perry V. Halushka, Richard W. Nesto, Julius Sagel, C B Loadholt, P.D. Winocour, Ronald K. Mayfield, Carlos Abraira and Kay E. Sarji and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

John A. Colwell

152 papers receiving 6.4k citations

Hit Papers

Cholesterol determination in high-density lipoproteins se... 1977 2026 1993 2009 1977 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Colwell United States 40 3.2k 1.9k 1.5k 905 864 154 7.1k
Raymond P. Bain United States 33 3.0k 0.9× 3.2k 1.7× 1.1k 0.7× 932 1.0× 545 0.6× 58 8.8k
H.‐H. Parving Denmark 56 4.3k 1.3× 3.9k 2.0× 1.1k 0.7× 828 0.9× 838 1.0× 138 9.9k
Mario Mancini Italy 51 2.0k 0.6× 2.1k 1.1× 1.7k 1.1× 880 1.0× 387 0.4× 259 7.4k
B. Lewis United Kingdom 46 3.1k 1.0× 1.8k 0.9× 3.2k 2.1× 825 0.9× 297 0.3× 149 7.0k
Michael W. Steffes United States 50 2.6k 0.8× 1.1k 0.6× 1.8k 1.2× 1.2k 1.4× 360 0.4× 144 8.8k
Gérald Luc France 46 2.6k 0.8× 3.0k 1.6× 3.1k 2.0× 1.8k 2.0× 649 0.8× 88 9.1k
Paola Fioretto Italy 53 4.1k 1.3× 1.9k 1.0× 2.0k 1.3× 1.9k 2.1× 611 0.7× 201 10.2k
Olga Vaccaro Italy 34 3.1k 1.0× 2.1k 1.1× 1.2k 0.8× 1.0k 1.1× 322 0.4× 126 6.2k
Roberto Pedrinelli Italy 39 1.8k 0.6× 3.6k 1.9× 958 0.6× 956 1.1× 556 0.6× 255 7.1k
Hiromichi Suzuki Japan 43 2.1k 0.6× 2.9k 1.5× 1.1k 0.7× 1.4k 1.6× 324 0.4× 408 8.5k

Countries citing papers authored by John A. Colwell

Since Specialization
Citations

This map shows the geographic impact of John A. Colwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Colwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Colwell more than expected).

Fields of papers citing papers by John A. Colwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Colwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Colwell. The network helps show where John A. Colwell may publish in the future.

Co-authorship network of co-authors of John A. Colwell

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Colwell. A scholar is included among the top collaborators of John A. Colwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Colwell. John A. Colwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colwell, John A., Steven Pratt, Paul Lant, & Bronwyn Laycock. (2023). Hazardous state lifetimes of biodegradable plastics in natural environments. The Science of The Total Environment. 894. 165025–165025. 39 indexed citations
2.
Chan, Clement Matthew, et al.. (2022). Characterisation of end groups of hydroxy-functionalised scl-PHAs prepared by transesterification using ethylene glycol. Polymer Degradation and Stability. 205. 110123–110123. 7 indexed citations
3.
Pignone, Michael, Mark J. Alberts, John A. Colwell, et al.. (2010). Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes. Journal of the American College of Cardiology. 55(25). 2878–2886. 73 indexed citations
4.
Colwell, John A.. (2009). Does aspirin use reduce cardiovascular risk in diabetes?. Nature Reviews Endocrinology. 5(4). 188–190. 3 indexed citations
5.
Colwell, John A.. (2006). Aspirin for the primary prevention of cardiovascular events. Drugs of today. 42(7). 467–467. 5 indexed citations
6.
Colwell, John A.. (2005). Is aspirin effective in diabetic patients? Yes. Journal of Thrombosis and Haemostasis. 3(12). 2612–2614. 5 indexed citations
7.
Colwell, John A.. (2004). Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus. American Journal of Cardiovascular Drugs. 4(2). 87–106. 20 indexed citations
8.
Colwell, John A.. (2000). Pathogenesis of vascular disease. Diabetes Obesity and Metabolism. 2(s2). 19–24. 14 indexed citations
9.
Azad, Nasrin, Nicholas Emanuele, Carlos Abraira, et al.. (1999). The Effects of Intensive Glycemic Control on Neuropathy in the VA Cooperative Study on Type II Diabetes Mellitus (VA CSDM). Journal of Diabetes and its Complications. 13(5-6). 307–313. 92 indexed citations
10.
Colwell, John A.. (1997). Multifactorial aspects of the treatment of the type II diabetic patient. Metabolism. 46(12 Suppl 1). 1–4. 15 indexed citations
11.
Colwell, John A., et al.. (1994). IMPLANTS FOR TYPE II DIABETIC PATIENTS. Implant Dentistry. 3(3). 183–187. 53 indexed citations
12.
Vinik, Aaron I. & John A. Colwell. (1993). Effects of Gemfibrozil on Triglyceride Levels in Patients With NIDDM: Hyperlipidemia in Diabetes Investigators. Diabetes Care. 16(1). 37–44. 25 indexed citations
13.
Colwell, John A.. (1992). Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus. Metabolism. 41(5). 7–10. 10 indexed citations
14.
Colwell, John A.. (1991). Pathophysiology of vascular disease in diabetes: Effects of gliclazide. The American Journal of Medicine. 90(6). S50–S54. 12 indexed citations
15.
Colwell, John A.. (1990). Qualitative market research: a conceptual analysis and review of practioner criteria. International Journal of Market Research. 32(1). 12 indexed citations
16.
Lyons, Timothy J., et al.. (1990). Hemostatic Alterations With Exercise Conditioning in NIDDM. Diabetes Care. 13(2). 87–92. 33 indexed citations
17.
Colwell, John A., Stephen F. Bingham, Carlos Abraira, et al.. (1989). V.A. Cooperative study of antiplatelet agents in diabetic patients after amputation for gangrene: Unobserved, sudden, and unexpected deaths. Journal of Diabetic Complications. 3(4). 191–197. 9 indexed citations
18.
Colwell, John A. & Maria F. Lopes‐Virella. (1988). A review of the development of large-vessel disease in diabetes mellitus. The American Journal of Medicine. 85(5). 113–118. 53 indexed citations
19.
Colwell, John A. & Stephen F. Bingham. (1986). VA Cooperative Study on Antiplatelet Agents in Diabetic Patients after Amputation for Gangrene. Pathophysiology of Haemostasis and Thrombosis. 16(6). 433–438. 12 indexed citations
20.
Colwell, John A., et al.. (1979). Platelet adhesion and aggregation in diabetes mellitus. Metabolism. 28(4). 394–400. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026